Other

Andrx Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc.

Andrx Labs, LLC

Andrx Corporation, Inc.

Dacheng Tian

Xiu Xiu Cheng

Avinash Nangia

Boyong Li

Jack Cardinal

Chih-Ming Chen

Unchalee Lodin

Nilobon Podhipleux

The present invention relates to a novel controlled release dosage form that releases therapeutic amounts of a sedative or hypnotic agent rapidly after administration and maintains therapeutic levels for about eight hours after administration.

Oral controlled release formulation for sedative and hypnotic agents

Disclosed is a controlled release formulation comprising valproic acid, pharmaceutically acceptable salt thereof, amide thereof, or derivative thereof.

Controlled release sodium valproate formulation

The present invention comprises a device and methods for dissolution or immersion testing and, in particular, a device and methods that improve the consistency of test results by limiting the ability of pharmaceutical or other dosage forms to move or reorient during testing.

Dosage form holder device and methods for immersion testing

A system and method for receiving and collecting particulate matter from drilled or cut holes in a tablet on a turntable and transporting said particulate to a remote location is described.

System and method for removing particulate created from a drilled or cut surface

This invention relates to an apparatus and method for regulating the delivery rate of bulk tablets to a tablet transportation system.

Apparatus and method for regulating the delivery of bulk tablets to a tablet transport system

A method for receiving and collecting particulate matter from drilled or cut holes in a tablet on a turntable and transporting said particulate to a remote location is described.

Growing community of inventors

Miramar, FL, United States of America

Dacheng Tian